Diagnostic algorithm with recommended complement testing and steps to define clinical significance of genetic variants in a patient with atypical hemolytic uremic syndrome (aHUS). AH50, alternative pathway activity; CH50, total hemolytic activity; FB, factor B; FH, factor H; FI, factor I; LDH, lactate dehydrogenase; MCP, membrane cofactor protein; VUS, variant of uncertain significance.